Ward van den Hoogen

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Saccharomyces Cerevisiae

Respiratory Syncytial Virus

Mesenchymal Stem Cells

Protein Protein

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Johannes P M Langedijk, Freek Cox, Nicole V Johnson, Daan van Overveld, Lam Le, Ward van den Hoogen, Richard Voorzaat, Roland C Zahn, Leslie van der Fits, Jarek Juraszek, Jason S Mclellan, Mark J G Bakkers
Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein. Nature communications 15 (1) (2024)
Johannes P M Langedijk, Freek Cox, Nicole V Johnson, Daan van Overveld, Lam Le, Ward van den Hoogen, Richard Voorzaat, Roland C Zahn, Leslie van der Fits, Jarek Juraszek, Jason S Mclellan, Mark J G Bakkers
Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein. Nature communications 15 (1) (2024)
Freek Cox, Eirikur Saeland, Anne Thoma, Ward van den Hoogen, Lisanne Tettero, Joke Drijver, Cornelis Vaneman, Yolinda van Polanen, Tina Ritschel, Arangassery Rosemary Bastian, Benoit Callendret, Roland C Zahn, Leslie van der Fits
RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models. Vaccines 11 (3) (2023)
Freek Cox, Eirikur Saeland, Anne Thoma, Ward van den Hoogen, Lisanne Tettero, Joke Drijver, Cornelis Vaneman, Yolinda van Polanen, Tina Ritschel, Arangassery Rosemary Bastian, Benoit Callendret, Roland C Zahn, Leslie van der Fits
RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models. Vaccines 11 (3) (2023)